 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Kiniksa Pharmaceuticals Ltd. (KNSA)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-02-13 Sale | 2020-02-18 6:05 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 11,316 | $18.29 | $207,011 | 18,000 (Direct) | View |
| 2020-02-14 Sale | 2020-02-19 5:24 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 59 | $18.58 | $1,096 | 79,530 (Direct) | View |
| 2020-02-19 Sale | 2020-02-21 4:57 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 32,280 | $18.48 | $596,487 | 18,000 (Direct) | View |
| 2020-03-06 Sale | 2020-03-10 5:33 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 33,115 | $20 | $662,300 | 212,570 (Indirect) | View |
| 2020-04-20 Sale | 2020-04-22 5:39 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 49,941 | $19.1 | $953,975 | 29,589 (Direct) | View |
| 2020-06-10 Sale | 2020-06-12 5:50 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 13,752 | $25.07 | $344,763 | 29,589 (Direct) | View |
| 2020-07-01 Sale | 2020-07-02 4:13 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 29,589 | $25.37 | $750,678 | 0 (Direct) | View |
| 2020-10-09 Sale | 2020-10-14 5:22 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 251,572 | $21.02 | $5,288,013 | 112,570 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-05-29 Option Award | 2019-05-30 6:33 pm | N/A 2029-05-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 18,760 | $15.47 | 18,760 (Direct) | View |
| 2019-05-29 Option Award | 2019-05-31 4:01 pm | N/A 2029-05-29 | Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 37,520 | $15.47 | 37,520 (Indirect) | View |
| 2019-05-29 Option Award | 2019-05-31 4:01 pm | N/A 2029-05-29 | Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 37,520 | $15.47 | 37,520 (Indirect) | View |
| 2019-06-06 Other | 2019-06-07 6:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 200,423 | $0 | 14,840 (Indirect) | View |
| 2019-06-06 Other | 2019-06-07 6:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 14,840 | $0 | 14,840 (Direct) | View |
| 2019-06-06 Other | 2019-06-07 6:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 14,840 | $0 | 14,840 (Direct) | View |
| 2019-09-17 Option Award | 2019-09-19 4:16 pm | N/A 2029-09-16 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 46,000 | $8.83 | 46,000 (Direct) | View |
| 2019-09-17 Option Award | 2019-09-19 4:16 pm | N/A 2029-09-16 | Kiniksa Pharmaceuticals Ltd. | KNSA | Heberlig Chris CFO | 50,000 | $8.83 | 50,000 (Direct) | View |
| 2019-09-17 Option Award | 2019-09-19 4:17 pm | N/A 2029-09-16 | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 190,000 | $8.83 | 190,000 (Direct) | View |
| 2019-09-17 Option Award | 2019-09-19 4:18 pm | N/A 2029-09-16 | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 45,000 | $8.83 | 45,000 (Direct) | View |
| 2019-09-17 Option Award | 2019-09-19 4:18 pm | N/A 2029-09-16 | Kiniksa Pharmaceuticals Ltd. | KNSA | Mahoney Stephen F. COO | 82,000 | $8.83 | 82,000 (Direct) | View |
| 2019-10-07 Exercise | 2019-10-09 4:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 10,000 | $1.86 | 217,574 (Direct) | View |
| 2019-10-07 Exercise | 2019-10-09 4:15 pm | N/A 2026-09-13 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 10,000 | $1.86 | 217,574 (Direct) | View |
| 2019-12-05 Exercise | 2019-12-09 5:57 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 8,000 | $1.86 | 209,574 (Direct) | View |
| 2019-12-05 Exercise | 2019-12-09 5:57 pm | N/A 2026-09-13 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 8,000 | $1.86 | 209,574 (Direct) | View |
| 2019-12-06 Option Award | 2019-12-09 5:58 pm | N/A 2029-12-05 | Kiniksa Pharmaceuticals Ltd. | KNSA | Rizvi Qasim Chief Commercial Officer | 30,000 | $10.61 | 30,000 (Direct) | View |
| 2019-12-12 Option Award | 2019-12-16 4:54 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Rizvi Qasim Chief Commercial Officer | 7,337 | $0 | 7,337 (Direct) | View |
| 2020-02-13 Exercise | 2020-02-18 6:05 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 10,277 | $3.8 | 18,000 (Direct) | View |
| 2020-02-13 Exercise | 2020-02-18 6:05 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 1,039 | $3.8 | 18,000 (Direct) | View |
| 2020-02-13 Exercise | 2020-02-18 6:05 pm | N/A 2027-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 10,277 | $3.8 | 18,000 (Direct) | View |
| 2020-02-13 Exercise | 2020-02-18 6:05 pm | N/A 2027-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 1,039 | $3.8 | 18,000 (Direct) | View |
| 2020-02-19 Exercise | 2020-02-21 4:57 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 22,477 | $3.8 | 18,000 (Direct) | View |
| 2020-02-19 Exercise | 2020-02-21 4:57 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 9,803 | $3.8 | 18,000 (Direct) | View |
| 2020-02-19 Exercise | 2020-02-21 4:57 pm | N/A 2027-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 22,477 | $3.8 | 18,000 (Direct) | View |
| 2020-02-19 Exercise | 2020-02-21 4:57 pm | N/A 2027-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 9,803 | $3.8 | 18,000 (Direct) | View |
| 2020-02-27 Exercise | 2020-03-02 5:48 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 12,000 | $1.86 | 197,574 (Direct) | View |
| 2020-02-27 Exercise | 2020-03-02 5:48 pm | N/A 2026-09-13 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 12,000 | $1.86 | 197,574 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-17 5:21 pm | N/A 2030-03-12 | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CAO | 17,000 | $15.52 | 17,000 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-17 5:22 pm | N/A 2030-03-12 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 50,000 | $15.52 | 50,000 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-17 5:22 pm | N/A 2030-03-12 | Kiniksa Pharmaceuticals Ltd. | KNSA | Rizvi Qasim Chief Commercial Officer | 75,000 | $15.52 | 75,000 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-17 5:23 pm | N/A 2030-03-12 | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 75,000 | $15.52 | 75,000 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-17 5:23 pm | N/A 2030-03-12 | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 180,000 | $15.52 | 180,000 (Direct) | View |
| 2020-05-18 Option Award | 2020-05-18 6:57 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 134,397 | $18.25 | 10,302,952 (Indirect) | View |
| 2020-05-18 Option Award | 2020-05-18 6:57 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 1,465,603 | $18.25 | 10,302,952 (Indirect) | View |
| 2020-06-10 Exercise | 2020-06-12 5:50 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 13,752 | $1.59 | 29,589 (Direct) | View |
| 2020-06-10 Exercise | 2020-06-12 5:50 pm | N/A 2025-12-15 | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 13,752 | $1.59 | 29,589 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-02 4:11 pm | N/A 2030-06-29 | Kiniksa Pharmaceuticals Ltd. | KNSA | McCain Tracey L Director | 18,760 | $25.48 | 18,760 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-02 4:11 pm | N/A 2030-06-29 | Kiniksa Pharmaceuticals Ltd. | KNSA | Popovits Kimberly J Director | 18,760 | $25.48 | 18,760 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-02 4:12 pm | N/A 2030-06-29 | Kiniksa Pharmaceuticals Ltd. | KNSA | Malley Thomas Director | 18,760 | $25.48 | 18,760 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-02 4:12 pm | N/A 2030-06-29 | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 18,760 | $25.48 | 18,760 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-02 4:14 pm | N/A 2030-06-29 | Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director | 18,760 | $25.48 | 18,760 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-02 5:53 pm | N/A 2030-06-30 | Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 37,520 | $25.48 | 37,520 (Indirect) | View |
| 2020-07-24 Option Award | 2020-07-28 5:32 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 93,210 | $21 | 11,638,314 (Indirect) | View |
| 2020-07-24 Option Award | 2020-07-28 5:32 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 1,335,362 | $21 | 11,638,314 (Indirect) | View |
| 2020-07-27 Option Award | 2020-07-29 5:46 pm | N/A 2030-07-26 | Kiniksa Pharmaceuticals Ltd. | KNSA | Cole G Bradley Director | 37,965 | $20.09 | 37,965 (Direct) | View |
| 2020-09-10 Option Award | 2020-09-14 5:06 pm | N/A 2030-09-09 | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CAO | 19,000 | $15.5 | 19,000 (Direct) | View |
| 2020-09-10 Option Award | 2020-09-14 5:09 pm | N/A 2030-09-09 | Kiniksa Pharmaceuticals Ltd. | KNSA | Rizvi Qasim Chief Commercial Officer | 75,000 | $15.5 | 75,000 (Direct) | View |
| 2020-09-10 Option Award | 2020-09-14 5:12 pm | N/A 2030-09-09 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 50,000 | $15.5 | 50,000 (Direct) | View |
| 2020-09-10 Option Award | 2020-09-14 5:14 pm | N/A 2030-09-09 | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 75,000 | $15.5 | 75,000 (Direct) | View |
| 2020-09-10 Option Award | 2020-09-14 5:16 pm | N/A 2030-09-09 | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 180,000 | $15.5 | 180,000 (Direct) | View |
| 2020-10-09 Exercise | 2020-10-14 5:22 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 872 | $1.59 | 112,570 (Direct) | View |
| 2020-10-09 Exercise | 2020-10-14 5:22 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 150,700 | $1.59 | 112,570 (Direct) | View |
| 2020-10-09 Exercise | 2020-10-14 5:22 pm | N/A 2025-12-15 | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 872 | $1.59 | 112,570 (Direct) | View |
| 2020-10-09 Exercise | 2020-10-14 5:22 pm | N/A 2025-12-15 | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 150,700 | $1.59 | 112,570 (Direct) | View |